Actions of galanin and some of its analogues on rat isolated gastric fundus

Fundamental and Clinical Pharmacology

Volumn 10, Issue 5, 1996, Pages 442-449

  Sliwinski W ^a   Korolkiewicz, R ^a   Rekowski, P ^b   Halama, A ^b   Korolkiewicz, K Z ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

Author keywords

Galanin; Galanin analogues; Gastric muscle; Rat

Indexed keywords

BUCLADESINE; CARBACHOL; DIBENAMINE; DILTIAZEM; GALANIN; GALANIN DERIVATIVE; GALANIN RECEPTOR; GLIBENCLAMIDE; PAPAVERINE;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; STOMACH FUNDUS; STOMACH MUSCLE;

EID: 0029744234     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1996.tb00599.x     Document Type: Article

References (39)

1. Amiranoff B, Lorinet AM, Lagny-Pourmir I, Laburthe M. Mechanism of galanin-inhibited insulin release: occurrence of a pertussis toxin-sensitive inhibition of adenylate cyclase. Eur J Biochem 1988;177:147-52
2. Barlow RB. Biodata handling with microcomputers. Programs written in BASIC for handling biological, biochemical, pharmacological and physicochemical results-with a commentary on the calculations involved. Amsterdam: Elsevier Science Publishers BV, 1983
3. Bartfai T. Galanin. A neuropeptide with important central nervous system actions. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press Ltd, 1995:563-71
4. Bartfai T, Bedecs K, Land T et al. M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord. Proc Nat Acad Sci USA 1991;88:10961-5
5. Bauer FE, Zintel A, Kenny MJ, Calder D, Ghatei MA, Bloom SR. Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Gastroenterology 1989;97:260-4
6. Bennet A, Stamford IF, Sanger GJ, Bloom SR. The effects of various peptides on human isolated gut muscle. J Pharm Pharmacol 1992;44:960-7
7. Bowman WC, Rand MJ. Principles of drug action. Identification and isolation of receptors. Affinity labelling. Dibenamine and related haloalkylamines. In: Bowman WC, Rand MJ, eds. Textbook of Pharmacology. 2nd ed. Oxford: Blackwell Scientific Publications, 1980a;chapter 39:53-5
8. Bowman WC, Rand MJ. The heart and drugs affecting cardiac function. Blood supply to the walls of the heart. Drugs that dilate the coronary vessels. Mechanisms of action. In: Bowman WC, Rand MJ, eds. Textbook of Pharmacology. 2nd ed. Oxford: Blackwell Scientific Publications, 1980b;chapter 22:5-10
9. Chan-Palay V. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 1988;273:543-57
10. Conlon JM, Deacon CF, O'Toole L, Thim L. Scyliorhinin I and II: two novel tachykinins from dogfish gut. FEBS Lett 1986;200:111-6
11. + channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone. Proc Natl Acad Sci USA 1988;85:1312-6
12. + channels in insulin secreting cells via a pertussis toxin-sensitive G protein. EMBO J 1989;8:413-20
13. 2+-dependent contractile effects on the isolated mouse distal colon. Eur J Pharmacol 1989;164:583-6
14. Furchgott RF. The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv Drug Res 1966;3:21-55
15. Gu ZFA, Rossowski WJ, Coy DH, Pradhan TK, Jensen RT. Chimeric galanin analogs that function as antagonists in the CNS are full agonists in gastrointestinal smooth muscle. J Pharmacol Exp Ther 1993;266:912-8
16. Karaki H, Murakami K, Nakagawa H, Ozaki H, Urakawa N. Effects of calmodulin antagonists on tension and cellular calcium content in depolarized vascular and intestinal smooth muscles. Br J Pharmacol 1982;77:661-6
17. 45Ca uptake in the smooth muscle of rabbit aorta, rat aorta and guinea pig Taenia coli. Br J Pharmacol 1984;81:393-400
18. Katsoulis S, Schmidt WE, Schwörer H, Creutzfeldt W. Effects of galanin, its analogues and fragments on rat isolated fundus strips. Br J Pharmacol 1990;101:297-300
19. Koshiyama H, Kato Y, Inoue T et al. Central galanin stimulates pituitary prolactin secretion in rats: possible involvement of hypothalamic vasoactive intestinal polypeptide. Neurosci Lett 1987;75:49-54
20. Lindskog S, Ahren B, Land T, Langel U, Bartfai T. The novel high-affinity antagonist, galantide blocks the galanin-mediated inhibition of glucose-induced insulin secretion. Eur J Pharmacol 1992;210:183-8
21. McDonald TJ, Dupre J, Tatemoto K, Greenberg GR, Radziuk J, Mutt V. Galanin inhibits insulin secretion and induces hyperglycaemia in dogs. Diabetes 1985;34:192-6
22. Melander T, Hökfelt T, Rökaeus A, Fahrenkrug J, Tatemoto K, Mutt V. Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species. Cell Tiss Res 1985;239:253-70
23. Ottlecz A, Samson WK, McCann SM. Galanin: evidence for a hypothalamic site of action to release growth hormone. Peptides 1986;7:51-5
24. Poćwiardowska-Ciara E, Rekowski P, Śliwiński W. Galantide contracts rat isolated fundus strips. Pharmacol Res 1995;31 (suppl):103A
25. Rekowski P, Halama A, Mucha P, Kupryszewski G, Poćwiardowska E, Korolkiewicz KZ. Galanin and its analogues: synthesis and studies of their agonist activity on smooth muscles. Pol J Chem 1993;67:233-44
26. Rökacus A. Galanin: a newly isolated biologically active neuropeptide. Trends Neurosci 1987;10:158-64
27. Rolka K. Tachykinins-structure and biological properties. Wiad Chem 1990;44:803-18 [in Polish]
28. Rolka K, Kupryszewski G, Janas P, Myszor J, Herman ZS. Synthesis and biological activity in GPI test of scyliorhinin I and its analogues modified in position 8 by Leu, Sar and Pro residues. Collect Czech Chem Commun 1991;56: 1957-62
29. Rossowski WJ, Rossowski TM, Zacharia S, Ertan A, Coy DH. Galanin binding sites in rat gastric and jejunal smooth muscle membranes preparations. Peptides 1990;11:333-8
30. Soldani G, Mengozzi G, Della-Longa A, Intorre L, Martelli F, Brown DR. An analysis of the effects of galanin on gastric acid secretion and plasma levels of gastrin in the dog. Eur J Pharmacol 1988;154:313-8
31. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994;372:231-6
32. Śliwiński W, Rekowski P, Halama A, Korolkiewicz R. Characteristics of interaction between galanin and its analogues with galanin receptor in the rat stomach fundus. Naunyn Schmiedebergs Arch Pharmacol 1995;352(suppl): R12-A47
33. Tallarida RJ, Murray RB. Manual of Pharmacologic Calculations with Computer Programs. 2nd ed. New York: Springer Verlag, 1986
34. Tallarida RJ, Raffa RB, McGonigle P. Radioligand binding. Direct binding. Hill plot. In: Tallarida RJ, Raffa RB, McGonigle P, eds. Principles in General Pharmacology. New York: Springer Verlag, 1988;chapter 9:211-2
35. 2+ dependence of smooth muscle contraction. J Biol Chem 1992;267:11839-45
36. Tatemoto K, Rökaeus A, Jörnvall H, McDonald TJ, Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 1983;164:124-8
37. Vane JR. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol 1957;12:344-9
38. + loss during hypoxia, ischemia and metabolic inhibition in mammalian ventricle. Circ Res 1991;69:623-37
39. Vrontakis ME, Torsello A, Friesen HG. Galanin. J Endocrinol Invest 1991;14:785-94